ArticleJournal of thoracic disease2019

Impact of clinical features on the efficacy of osimertinib treatment in epidermal growth factor receptor mutant non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors due to T790M mutation.

Chong-Kin Liam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.